Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Advances in Neuropharmacology -

Advances in Neuropharmacology

Drugs and Therapeutics
Buch | Hardcover
621 Seiten
2020
Apple Academic Press Inc. (Verlag)
978-1-77188-797-7 (ISBN)
CHF 399,95 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Provides a comprehensive overview of the drugs that act on the central and peripheral nervous systems. It thoroughly describes the diseases that are associated with the nervous system and drugs used their treatment while also looking at the current status of these drugs and their future potential and challenges.
Here is a comprehensive overview of the drugs that act on the central and peripheral nervous systems. This volume thoroughly describes the diseases associated with the nervous system and the drugs used for their treatment while also looking at the current status of these drugs and their future potential and challenges.



Divided into three sections, the book first focuses on the drugs that affect the functions of the autonomic nervous system to produce therapeutic effects. These drugs may act presynaptically by manipulating the genesis, storage, and secretion, and by blocking the action of neurotransmitters. Some drugs may trigger or impede postsynaptic receptors. Section 2 focuses on drugs that affect the central nervous system, including antianxiety drugs, sedative and hypnotic drugs, antidepressant drugs, antipsychotic drugs, antiepileptic drugs, and many more. It covers the pharmacological management of various diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and others. The last section offers explanations of neurochemical interactions with the aim to develop drugs that have beneficial effects on neurochemical imbalances. This section demonstrates models to assess the transport of drugs across the blood-brain barrier and nanomedicine to treat brain disorders.



This rich compilation provides thorough and extensive research updates on the important advances in neuropharmacological drugs and drug therapy from experienced and eminent academicians, researchers, and scientists from throughout the world.

Md. Sahab Uddin, RPh, is a Registered Pharmacist and a Research Scholar in the Department of Pharmacy at Southeast University, Dhaka, Bangladesh. He is the author of more than 100 articles in peer-reviewed international scientific journals as well as the author and editor of several books. He also serves as a reviewer and editorial board member of more than 80 scholarly journals. He is the Founder and CEO of the Pharmakon Neuroscience Research Network, an open innovation hub that brings together neuroscientists to advance brain health. Mamunur Rashid, PhD, is a Professor in the Department of Pharmacy at the University of Rajshahi, Rajshahi, Bangladesh, where he also served as Chairman of the department. He previously worked as a visiting scientist at the Department of Pharmacology, Niigata University of Pharmacy and Applied Life Sciences, Japan. He was also the Chairman of the Department of Pharmacy, Southeast University, Bangladesh. He is a member of the Bangladesh Pharmaceutical Society. He also works for the development of the pharmaceutical sector in Bangladesh. He has made a vast contribution to the promotion of pharmacy education and the pharmacy profession to create better opportunities for Bangladeshi pharmacists. He is one of the pioneers who are working with the Commonwealth Pharmacists Association and Bangladesh Pharmaceutical Society to develop hospital and community pharmacy in Bangladesh. He has published 75 articles and 23 abstracts in conference proceedings.

Part 1: Drugs Affecting The Autonomic Nervous System 1. Cholinergic Agonists 2. Cholinergic Antagonists 3. Adrenergic Agonists 4. Adrenergic Antagonists Part 2: Drugs Affecting The Central Nervous System 5. Pharmacological Management of Alzheimer’s Disease 6. Pharmacological Management of Parkinson’s Disease 7. Pharmacological Management of Huntington’s Disease 8. Pharmacological Management of Amyotrophic Lateral Sclerosis 9. Antianxiety Drugs 10. Antimanic Drugs 11. Sedative and Hypnotic Drugs 12. Antidepressant Drugs 13. Antipsychotic Drugs 14. Antiepileptic Drugs 15. Local Anesthetics 16. General Anesthetics 17. Alcohol Pharmacology and Pharmacotherapy of Alcoholism 18. Cognition Enhancers 19. Opioids Analgesics and Antagonists 20. Drugs of Abuse and Addiction 21. Therapeutic Gases for Neurological Disorders Part 3: Miscellaneous Drugs 22. Pharmacotherapy of Neurochemical Imbalances 23. Evaluation Models for Drug Transport Across Blood-Brain Barrier 24. Therapeutic Potentials of Nanomedicine for Brain Disorders

Erscheinungsdatum
Zusatzinfo 86 Tables, black and white; 7 Illustrations, color; 94 Illustrations, black and white
Verlagsort Oakville
Sprache englisch
Maße 191 x 241 mm
Gewicht 1605 g
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Biologie Humanbiologie
Naturwissenschaften Biologie Zoologie
ISBN-10 1-77188-797-4 / 1771887974
ISBN-13 978-1-77188-797-7 / 9781771887977
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 135,75